These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10335017)

  • 1. Methodological issues in evaluating Rorschach validity: a comment on Burns and Viglione (1996), Weiner (1996), and Ganellen (1996).
    Wood JM; Nezworski MT; Stejskal WJ; Garven S; West SG
    Assessment; 1999 Jun; 6(2):115-29. PubMed ID: 10335017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weighing evidence for the Rorschach's validity: a response to Wood et al. (1999).
    Ganellen RJ
    J Pers Assess; 2001 Aug; 77(1):1-15. PubMed ID: 11562095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the science of Rorschach research.
    Meyer GJ
    J Pers Assess; 2000 Aug; 75(1):46-81. PubMed ID: 10941702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations between Minnesota Multiphasic Personality Inventory-A scales and Rorschach variables with the scope and severity of maltreatment among adolescents.
    Perfect MM; Tharinger DJ; Keith TZ; Lyle-Lahroud T
    J Pers Assess; 2011 Nov; 93(6):582-91. PubMed ID: 21999381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rorschach revised DEPI and CDI with inpatient Major Depressives and Borderline Personality Disorder with major depression: validity issues.
    Carlson CF; Kula ML; St Laurent CM
    J Clin Psychol; 1997 Jan; 53(1):51-8. PubMed ID: 9120032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelationship between MMPI-2 and Rorschach variables in a sample of Vietnam veterans with PTSD.
    Frueh BC; Leverett JP; Kinder BN
    J Pers Assess; 1995 Apr; 64(2):312-8. PubMed ID: 7722856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Rorschach distress correlates to malingering.
    Meisner S
    J Pers Assess; 1988; 52(3):564-71. PubMed ID: 3210128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A replication of Rorschach and MMPI-2 convergent validity.
    Meyer GJ; Riethmiller RJ; Brooks RD; Benoit WA; Handler L
    J Pers Assess; 2000 Apr; 74(2):175-215. PubMed ID: 10879351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coming to grips with negative evidence for the Comprehensive System for the Rorschach: a comment on Gacono, Loving, and Bodholdt; Ganellen; and Bornstein.
    Wood JM; Lilienfeld SO; Nezworski MT; Garb HN
    J Pers Assess; 2001 Aug; 77(1):48-70. PubMed ID: 11562104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating the Rorschach and the MMPI in clinical assessment: conceptual and methodological issues.
    Acklin MW
    J Pers Assess; 1993 Feb; 60(1):125-31. PubMed ID: 8433262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of borderline personality disorder. A review of MMPI and Rorschach findings.
    Zalewski C; Archer RP
    J Nerv Ment Dis; 1991 Jun; 179(6):338-45. PubMed ID: 2051148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating psychotic patients from nonpsychotic patients with the MMPI-2 and Rorschach.
    Dao TK; Prevatt F; Horne HL
    J Pers Assess; 2008 Jan; 90(1):93-101. PubMed ID: 18444100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rorschach test in clinical diagnosis: a critical review, with a backward look at Garfield (1947).
    Wood JM; Lilienfeld SO; Garb HN; Nezworski MT
    J Clin Psychol; 2000 Mar; 56(3):395-430; discussion 431-4. PubMed ID: 10726675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Rorschach Comprehensive System (CS) Psychometric Validity of Individual Variables.
    Tibon Czopp S; Zeligman R
    J Pers Assess; 2016; 98(4):335-42. PubMed ID: 27153465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying the Rorschach Human Experience Variable to create the Human Representational Variable.
    Viglione DJ; Perry W; Jansak D; Meyer G; Exner JE
    J Pers Assess; 2003 Aug; 81(1):64-73. PubMed ID: 12842803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMPI and Rorschach indices of schizophrenic and depressive diagnoses among adolescent inpatients.
    Archer RP; Gordon RA
    J Pers Assess; 1988; 52(2):276-87. PubMed ID: 3404390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rorschach and MMPI-2 indices of early psychotherapy termination.
    Hilsenroth MJ; Handler L; Toman KM; Padawer JR
    J Consult Clin Psychol; 1995 Dec; 63(6):956-65. PubMed ID: 8543718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial validity of the Logical Rorschach in the assessment of trauma.
    Smith SR; Chang J; Kochinski S; Patz S; Nowinski LA
    J Pers Assess; 2010 May; 92(3):222-31. PubMed ID: 20408022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rorschach Inkblot Test: a case of overstatement?
    Wood JM; Lilienfeld SO
    Assessment; 1999 Dec; 6(4):341-52. PubMed ID: 10539981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The susceptibility of the Rorschach Inkblot Test to malingering of combat-related PTSD.
    Frueh BC; Kinder BN
    J Pers Assess; 1994 Apr; 62(2):280-98. PubMed ID: 8189337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.